Age: 17.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Rash, Urticaria
Clinical narrative: red raised rash/ on my sons face, down his back on his legs/ than spread to his whole body; nickel sized hives/ on chest, tummy, arms, hives around his arm pits on his hands; Swollen face; Swollen face, eyelids; Swollen face, eyelids, and nose; Swollen face, eyelids, and nose, lips; pain; feeling sick; This is a spontaneous report received from contactable reporter (Consumer or other non HCP). The reporter is the parent.  A 17-year-old male patient received bnt162b2 (BNT162B2), administered in arm right, administration date 22Feb2022 14:30 (Lot number: 330258D) at the age of 17 years as dose 3 (booster), single for COVID-19 immunisation. Relevant medical history included: "Autism" (unspecified if ongoing); "intellectual disability" (unspecified if ongoing); "mood disorder" (unspecified if ongoing). The patient had COVID-19 prior vaccination. Concomitant medications included: CLONIDINE; PEPCID; ZYRTEC; TEGRETOL; FLUXAMINE. Past drug history included: Codeine, reaction(s): "vomiting"; Claritin, reaction: "hallucinations"; Risperdal, reaction: "acute torticollis". Vaccination history included: Bnt162b2 (Dose Number: 2, Batch/Lot No: Ew0171, Location of injection: Arm Right), administration date: 30Apr2021, when the patient was 16 years old, for COVID-19 Immunization; Bnt162b2 (Dose Number: 1, Batch/Lot No: ER8732, Location of injection: Arm Right), administration date: 01Apr2021, when the patient was 16 years old, for COVID-19 Immunization. The following information was reported: RASH ERYTHEMATOUS (non-serious) with onset 01Mar2022 07:00, outcome "not recovered", described as "red raised rash/ on my sons face, down his back on his legs/ than spread to his whole body"; URTICARIA (non-serious) with onset 01Mar2022 07:00, outcome "not recovered", described as "nickel sized hives/ on chest, tummy, arms, hives around his arm pits on his hands"; SWELLING FACE (non-serious) with onset 01Mar2022 07:00, outcome "not recovered", described as "Swollen face"; SWELLING OF EYELID (non-serious) with onset 01Mar2022 07:00, outcome "not recovered", described as "Swollen face, eyelids"; NASAL OEDEMA (non-serious) with onset 01Mar2022 07:00, outcome "not recovered", described as "Swollen face, eyelids, and nose"; LIP SWELLING (non-serious) with onset 01Mar2022 07:00, outcome "not recovered", described as "Swollen face, eyelids, and nose, lips"; PAIN (non-serious) with onset 01Mar2022 07:00, outcome "not recovered", described as "pain"; MALAISE (non-serious) with onset 01Mar2022 07:00, outcome "not recovered", described as "feeling sick". The events "red raised rash/ on my sons face, down his back on his legs", "nickel sized hives/ on chest, tummy, arms, hives around his arm pits on his hands", "swollen face", "swollen face, eyelids", "swollen face, eyelids, and nose", "swollen face, eyelids, and nose, lips", "pain" and "feeling sick" were evaluated at the physician office visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of rash erythematous, urticaria, swelling face, swelling of eyelid, nasal oedema, lip swelling, pain, malaise, and included prednisone 5 days, antibiotics, prednisone 10 days.  Additional information: on 01Mar2022 red raised rash and nickel sized hives all over. The red raised rash was on reporter's son face, down his back on his legs, nickel sized hives on chest, tummy, arms, hives around his arm pits on his hands, the red raised rash had than spread to his whole body. Swollen face, eyelids, and nose, lips, hives and rash hurt reporter's son he was autistic and he was feeling sick and in pain.